1. Home
  2. POCI vs LTRN Comparison

POCI vs LTRN Comparison

Compare POCI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

N/A

Current Price

$4.22

Market Cap

47.8M

Sector

Health Care

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$1.03

Market Cap

27.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POCI
LTRN
Founded
1982
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.8M
27.6M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
POCI
LTRN
Price
$4.22
$1.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
50.9K
★ 236.0K
Earning Date
09-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 49.41
18.65
EPS
★ N/A
N/A
Revenue
★ $31,531,765.00
N/A
Revenue This Year
$56.65
N/A
Revenue Next Year
$15.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 65.16
N/A
52 Week Low
$3.55
$1.01
52 Week High
$6.15
$4.70

Technical Indicators

Market Signals
Indicator
POCI
LTRN
Relative Strength Index (RSI) 42.05 18.64
Support Level $4.05 N/A
Resistance Level $4.25 $1.96
Average True Range (ATR) 0.22 0.17
MACD -0.03 -0.03
Stochastic Oscillator 19.04 4.12

Price Performance

Historical Comparison
POCI
LTRN

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: